HighVista Strategies LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1335325 BOSTON, MA

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,019,177

+$1,046,764 QoQ

Shares Held

130,784

+5.5% QoQ

Ownership

0.183%

of shares outstanding

% of Portfolio

1.60%

of 13F equity value

Holder Rank

#50

of 190 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. GPCR ranks #10 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,019,177	130,784	+5.5%	Shares	Sole	2026-08-14
2026-03-31	$5,972,413	123,909	-35.8%	Shares	Sole	2026-05-15
2025-12-31	$13,423,219	193,001	-18.3%	Shares	Sole	2026-02-17
2025-09-30	$6,614,608	236,236	+172.7%	Shares	Sole	2025-11-14
2025-06-30	$1,796,519	86,621	+393.3%	Shares	Sole	2025-08-14
2025-03-31	$303,980	17,561	0.0%	Shares	Sole	2025-05-15
2024-12-31	$476,254	17,561	-44.6%	Shares	Sole	2025-02-14
2024-09-30	$1,392,103	31,718	-9.7%	Shares	Sole	2024-11-14
2024-06-30	$1,379,476	35,128	-6.2%	Shares	Sole	2024-08-14
2024-03-31	$1,604,849	37,444	-50.0%	Shares	Sole	2024-05-15
2023-12-31	$3,050,152	74,832	0.0%	Shares	Sole	2024-02-14
2023-09-30	$3,773,029	74,832	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.